Dry Eye Disease Clinical Trials

A listing of Dry Eye Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 111 clinical trials
Featured trial
A Double-Masked , Randomized, Multi-Center Phase1/2 Study to Evaluate the Efficacy and Safety of the Drug in Subjects with Dry Eye Associated with Sjogren's Syndrome.

A Double-Masked , Randomized, Multi-Center Phase1/2 Study to Evaluate the Efficacy and Safety of the Drug in Subjects with Dry Eye Associated with Sjogren's Syndrome.

  • 978 views
  • 25 Mar, 2021
  • 1 location
Morphological Analysis of Meibomian Glands

: (1) to compared the detailed characteristics of morphology of meibomian glands in normal subjects, Meibomian gland dysfunction (MGD) patients and aqueous deficiency dry eye (ADDE) patients by the

deficiency
dry eye syndrome
Accepts healthy volunteers
  • 0 views
  • 22 Apr, 2022
  • 2 locations
Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction

This study is to evaluate the effectiveness of E>EYE intense regulated pulsed light (IRPL) treatment compared to the current standard of care using a daily warm compress

  • 18 views
  • 04 Oct, 2022
  • 1 location
Initial Correction Keratoconus

Keratoconus is a non-inflammatory, progressive disease in which corneal irregularity increases. As the condition develops, more advanced forms of optical correction are needed to improve vision for patients. Until recently, small diameter corneal gas permeable lenses were considered the primary mode of correction for patients with keratoconus. Now, however, practitioners …

  • 0 views
  • 03 Jun, 2022
  • 4 locations
GAG-therapy Efficacy Trial Solution for Bladder Pain Syndrome/ Interstitial Cystitis (GETSBI Study) (GETSBI)

Rationale Efficacy study (RCT) for glycosaminoglycan(GAG)-therapy for the indication bladder pain syndrome / interstitial cystitis with Hunner lesion subtype (BPS-IC H+). reason for this study is a current lack of evidence regarding its efficacy and cost-effectiveness. Main objective is to determine short and long term efficacy of GAG therapy (bladder …

  • 7 views
  • 07 Oct, 2022
  • 7 locations
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease

The purpose of this study is to assess the efficacy and safety of K-161 ophthalmic solution for the treatment of moderate to severe dry eye disease.

  • 0 views
  • 19 Jun, 2022
  • 1 location
Clinical Applications of Advanced Ophthalmic Imaging

The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls. There are two phases in this study. The first phase is an observational phase …

disease or disorder
mild cognitive impairment
edema
dry eyes
optical coherence tomography
  • 630 views
  • 28 Oct, 2022
  • 1 location
A Phase 3, Randomized, Multi-Regional, Double-Masked, Parallel-Group Trial Evaluating the Safety and Efficacy of NCX 470 0.1% vs. Latanoprost 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali) (Denali)

The objective of this clinical study is to evaluate the safety and efficacy of NCX 470 Ophthalmic Solution in lowering intraocular pressure (IOP) in subjecs with ocular hypertension or open-angle glaucoma. Subjects will be randomized in a 1:1 ratio to NCX 470 0.1% or to latanoprost 0.005% to be administered …

intraocular pressure
hypertension
glaucoma
corrected visual acuity
ophthalmic solution
  • 1 views
  • 11 Oct, 2022
  • 1 location
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle glaucoma (OAG) or ocular hypertension (OHT) who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy.

bimatoprost
hypertension
intraocular pressure
glaucoma
pigmentary glaucoma
  • 426 views
  • 22 Oct, 2022
  • 101 locations
Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits

Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform …

diabetes
glaucoma
visual loss
eye disease
Accepts healthy volunteers
  • 0 views
  • 22 Apr, 2022
  • 1 location